The article highlights critical flaws in the U.S. healthcare system, which consumes over 17% of GDP. While it excels in medical education and research, it struggles with rising costs and accessibility challenges. The influence of private insurance and pharmaceutical companies exacerbates issues, leading to significant lobbying expenditures. The disparity in healthcare costs is stark, with U.S. expenses significantly higher than those of peers, affecting millions who face tough choices between essential needs like food and healthcare and leaving many uninsured.
Efforts to address such fundamental failings are complicated by vested interests of private insurance companies, private healthcare, and pharmaceutical companies, which wield disproportionate influence over policy.
Payments in the form of inpatient or outpatient care average around $7,500 per person in the U.S., as compared to just under $3,000 on average among peer countries.
Collection
[
|
...
]